After 4 weeks of treatment, fasting hyperglycemia and hyperinsulinemia in HFD-fed mice were significantly improved, and fasting serum NEFA, 3-hydroxybutyrate, and plasma glucagon levels were significantly increased by ipragliflozin treatment (Table 1). This evidence concerns the gene GCG and hyperinsulinism.